News
Physiological and Clinical Effect of Romiplostim in the Treatment of ITP
Romiplostim in the treatment of immune thrombocytopenia (ITP) has demonstrated safety and the promise of long-term remission, enabling many pediatric and adult patients to discontinue treatment and maintain a drug-free state.
Administration of Romiplostim in Patients with ITP in Real-World Practice in Central Europe
Data from the PLATON study on the administration of romiplostim in real-world clinical practice in…
Vaccination Against COVID-19 in Patients Treated With Anticoagulants
Canadian professional societies and the National Health Service (NHS) in the United Kingdom…
Importance of Testing for Iron Deficiency in Patients with Chronic Heart Failure and Treatment Options
Intravenous iron application in patients with heart failure and iron deficiency is now part of ESC…
Effects of Metformin on the Cardiovascular System of Patients with Diabetes, but Also Without It
Diabetes mellitus (DM) is considered an independent risk factor for the development of ischemic…
Recommendations for Lipid Administration in Patients on Home Parenteral Therapy
Home parenteral therapy is an important part of treatment for patients with chronic intestinal…
No deficiency of essential fatty acids in home parenteral nutrition
A Dutch-British study, the results of which were published in the Journal of Parenteral and Enteral…
Does Administration of Saline Make a Crucial Difference Compared to Balanced Crystalloids in Critically Ill Patients?
A study published in the New England Journal of Medicine provided data on mortality and…
Nutritional Therapy for Critically Ill Patients in the ICU – Current Recommendations
Critically ill patients hospitalized in the intensive care unit (ICU) require nutritional support…
Efficacy and Safety of Enoxaparin as Bridging Anticoagulant Therapy After Ventricular Assist Device Implantation
The implantation of a ventricular assist device has become an increasingly common method in the…